US equities |
MU $1,045.56 ▲+0.00% INTC $112.50 ▲+0.00% NVDA $239.24 ▲+0.00% AMD $649.42 ▲+0.00% SNDK $1,660.46 ▲+0.00% SPCX $171.92 ▲+0.00% MRVL $287.01 ▲+0.00% PG $148.41 ▲+0.00%
FinancialContent

Latest News about Phase 2B Trial

Recent news which mentions Phase 2B Trial

Cara Therapeutics' Difelikefalin Aces Mid-Stage Study In Patients With Itchy Skin Disorder
Tickers CARA
Tags Market News CARA Biotech
From Benzinga
Capricor Shares Fall After Topline Results From Mid-Stage COVID-19 Trial
Tickers CAPR
Tags Briefs News why it's moving
From Benzinga